Zim Laboratories Ltd. Announces Q3 Results with 10.87 Billion Revenue and Approves Investment in Chile Subsidiary

Zim Laboratories Ltd. has announced its unaudited consolidated financial results for the quarter and nine months ended 31st December 2025. The company reported a revenue from operations of 10,865.93 million and a total income of 11,036.08 million. The expenses for the quarter were 10,431.40 million, resulting in a profit before tax of 604.68 million and a profit after tax of 439.76 million. The company also announced an investment of up to USD 15,000 for incorporating a wholly owned subsidiary in Chile. The board meeting to approve these decisions was held on 11th February 2026.